OPKO Health Inc (OPK):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:OPKO Health Inc (OPK) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7252
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
OPKO Health Inc (OPKO) discovers, develops, manufactures and commercializes novel diagnostic technologies and pharmaceuticals. The company’s product portfolio includes point-of-care tests, laboratory developed tests (LDTs), molecular diagnostics tests, and proprietary pharmaceuticals and vaccines. It offers its diagonostics and therapeutics that are used in the treatment of chronic kidney disease, obesity, asthma, chronic obstructive pulmonary disease (COPD), cancer and chemotherapy-induced nausea and vomiting, among others. It also offers neutraceuticals and veterinary products.The company also offers contract research services to other pharmaceutical companies. The company has its operational presence with its offices located in Chile, Mexico, Spain, Ireland, Canada and Israel. OPKO is headquartered in Miami, Florida, the US.

OPKO Health Inc (OPK) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
OPKO Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OPKO Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OPKO Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OPKO Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 9
OPKO Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
OPKO Health Inc, Medical Equipment, Deal Details 12
Venture Financing 12
InCellDx Raises US$4 Million In Venture Financing 12
Partnerships 13
Opko Health Enters Into Licensing Agreement With International Health Technology For Prostate Cancer Biomarker Panel 13
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer’s Diagnostic Technology 14
OPKO Health Enters Into Licensing Agreement With Arctic Partners For Biomakers 15
GeneDx Enters into Research Agreement with Radboud University 16
North Shore-LIJ Health System and OPKO Health Enter into Partnership 17
Opko Health Expands Co-Development Agreement With Bristol-Myers Squibb For Alzheimer’s Biomarkers 18
Bio-Reference Labs Enters Into Licensing Agreement With University of Washington 19
Genetic Technologies Enters Into Licensing Agreement With Bio-Reference Labs 20
OPKO Health Enters Into Licensing Agreement With BioZone Pharma For Drug Delivery Platforms 21
Equity Offering 22
Arno Therapeutics Raises USD2.3 Million in First Tranche of Private Placement of Units 22
Arno Therapeutics Completes Private Placement Of Units For US$30.7 Million 24
Neovasc Completes Private Placement Of Shares For US$2.2 Million Upon Exercise Of Warrants 26
Debt Offering 27
OPKO Health Raises USD55 Million in Public Offering of 5% Notes Due 2023 27
Opko Health Completes Private Placement Of Notes Due 2033 For US$175 Million 28
Acquisition 30
Opko Health Acquires Bio-Reference Labs 30
Opko Health Acquires Inspiro Medical 32
Opko Health Completes Acquisition Of Laboratorio Arama 33
BioReference Labs To Acquire Edge Bioserv From Edge BioSystems 34
Opko Health Completes Acquisition Of Silcon Comercio 35
OPKO Health Inc – Key Competitors 36
OPKO Health Inc – Key Employees 37
OPKO Health Inc – Locations And Subsidiaries 38
Head Office 38
Other Locations & Subsidiaries 38
Recent Developments 41
Strategy And Business Planning 41
Sep 19, 2017: OPKO’s BioReference Laboratories and The Garage Announce National Strategic Affiliation to Enhance Value-Based Care 41
Financial Announcements 42
Aug 07, 2018: Opko Health announces second quarter 2018 financial results 42
May 08, 2018: OPKO Health Announces First Quarter 2018 Financial Results 43
Mar 01, 2018: OPKO Health Reports 2017 Fourth Quarter Business Highlights and Financial Results 45
Nov 08, 2017: OPKO Health Reports 2017 Third Quarter Highlights and Financial Results 47
Aug 08, 2017: OPKO Health Reports Second Quarter 2017 Business and Financial Results 48
May 09, 2017: OPKO Health Reports 2016 Financial and Operating Results 50
Mar 01, 2017: OPKO Health Reports 2016 Financial and Operating Results 51
Corporate Communications 53
May 01, 2018: OPKO Health Appoints Geoff Monk General Manager at BioReference Laboratories 53
Jan 26, 2018: OPKO Health Announces Resignation Of Gregory Henderson As President Of BioReference Laboratories 54
Sep 06, 2017: Sandra Cole Appointed Vice President and Chief Compliance Officer for OPKO’s BioReference Laboratories 55
Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO’s BioReference Laboratories 56
Mar 03, 2017: OPKO Health Appoints Dr. Akhtar Ashfaq as Renal Division Senior Vice President, Clinical Research and Development 57
Product News 58
Sep 12, 2017: OPKO’s GeneDx to Showcase Leadership in Genetic Testing at the National Society of Genetic Counselors and the American Society of Human Genetics Annual Meetings 58
Other Significant Developments 59
Feb 28, 2017: OPKO Health’s GeneDx Announces Participation in Illumina’s iHope Program on International Rare Disease Day 59
Appendix 60
Methodology 60
About GlobalData 60
Contact Us 60
Disclaimer 60

List of Tables
OPKO Health Inc, Medical Equipment, Key Facts, 2017 2
OPKO Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
OPKO Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OPKO Health Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 7
OPKO Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OPKO Health Inc, Deals By Market, 2012 to YTD 2018 9
OPKO Health Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 10
InCellDx Raises US$4 Million In Venture Financing 12
Opko Health Enters Into Licensing Agreement With International Health Technology For Prostate Cancer Biomarker Panel 13
LabCorp Enters Into Licensing Agreement With OPKO Health For Alzheimer's Diagnostic Technology 14
OPKO Health Enters Into Licensing Agreement With Arctic Partners For Biomakers 15
GeneDx Enters into Research Agreement with Radboud University 16
North Shore-LIJ Health System and OPKO Health Enter into Partnership 17
Opko Health Expands Co-Development Agreement With Bristol-Myers Squibb For Alzheimer's Biomarkers 18
Bio-Reference Labs Enters Into Licensing Agreement With University of Washington 19
Genetic Technologies Enters Into Licensing Agreement With Bio-Reference Labs 20
OPKO Health Enters Into Licensing Agreement With BioZone Pharma For Drug Delivery Platforms 21
Arno Therapeutics Raises USD2.3 Million in First Tranche of Private Placement of Units 22
Arno Therapeutics Completes Private Placement Of Units For US$30.7 Million 24
Neovasc Completes Private Placement Of Shares For US$2.2 Million Upon Exercise Of Warrants 26
OPKO Health Raises USD55 Million in Public Offering of 5% Notes Due 2023 27
Opko Health Completes Private Placement Of Notes Due 2033 For US$175 Million 28
Opko Health Acquires Bio-Reference Labs 30
Opko Health Acquires Inspiro Medical 32
Opko Health Completes Acquisition Of Laboratorio Arama 33
BioReference Labs To Acquire Edge Bioserv From Edge BioSystems 34
Opko Health Completes Acquisition Of Silcon Comercio 35
OPKO Health Inc, Key Competitors 36
OPKO Health Inc, Key Employees 37
OPKO Health Inc, Other Locations 38
OPKO Health Inc, Subsidiaries 38

List of Figures
OPKO Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
OPKO Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
OPKO Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
OPKO Health Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
OPKO Health Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 6
OPKO Health Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 7
OPKO Health Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 8
OPKO Health Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 9

★海外企業調査レポート[OPKO Health Inc (OPK):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • DecImmune Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary DecImmune Therapeutics Inc (DecImmune) is a pharmaceutical research company. The company develops a humanised antibody, which is used in preventing tissue damage and block inflammation caused from vascular injuries. It conducts research and development on N2, an innate IgM-mediated auto-immu …
  • The AES Corp:企業の発電所・SWOT分析2018
    The AES Corp - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execu …
  • Verseon Corp (VSN):企業の財務・戦略的SWOT分析
    Summary Verseon Corp (Verseon) is a pharmaceutical company that develops novel therapeutics. The company develops drug programs in the therapeutic areas of anticoagulation, diabetic macular edema, hereditary angioedema, and oncology. Its anticoagulation program develops oral anticoagulants for cardi …
  • Brioche Pasquier S.A.:企業の戦略・SWOT・財務分析
    Brioche Pasquier S.A. - Strategy, SWOT and Corporate Finance Report Summary Brioche Pasquier S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Erytech Pharma SA (ERYP):製薬・医療:M&Aディール及び事業提携情報
    Summary Erytech Pharma SA (Erytech) is a clinical-stage biopharmaceutical company that provides development of therapies for rare forms of cancer and orphan diseases. The company develops pipeline of product candidates through its proprietary ERYCAPS platform. It offers product candidates which are …
  • PT Garuda Indonesia (Persero) Tbk:企業の戦略・SWOT・財務情報
    PT Garuda Indonesia (Persero) Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Garuda Indonesia (Persero) Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • ShawCor Ltd (SCL):企業の財務・戦略的SWOT分析
    ShawCor Ltd (SCL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Daewoo Shipbuilding & Marine Engineering Co Ltd:戦略・SWOT・企業財務分析
    Daewoo Shipbuilding & Marine Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Daewoo Shipbuilding & Marine Engineering Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, o …
  • Align Technology Inc (ALGN):企業の財務・戦略的SWOT分析
    Align Technology Inc (ALGN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Intermountain Healthcare Inc-医療機器分野:企業M&A・提携分析
    Summary Intermountain Healthcare Inc (Intermountain Healthcare) is a non-profit health care system. It provides health care services to Utah and Southeastern Idaho residents. It offers a wide range of clinical programs covering cardiovascular, intensive medicine, primary care, pediatric specialties, …
  • Noevir Holdings Co Ltd (4928):企業の財務・戦略的SWOT分析
    Noevir Holdings Co Ltd (4928) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Power Mech Projects Ltd (POWERMECH):企業の財務・戦略的SWOT分析
    Power Mech Projects Ltd (POWERMECH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Mayne Pharma Group Ltd (MYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, …
  • Coretex Products, Inc.:企業の戦略・SWOT・財務情報
    Coretex Products, Inc. - Strategy, SWOT and Corporate Finance Report Summary Coretex Products, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • HTL International Holdings Limited:企業の戦略的SWOT分析
    HTL International Holdings Limited - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major …
  • Argon Medical Devices Inc:医療機器:M&Aディール及び事業提携情報
    Summary Argon Medical Devices Inc (Argon) is a medical device company that manufactures and supplies products for the dialysis and others. The company provides arterial catheters, temporary pacing electrode trays, pulmonary artery and thermodilution catheters, and single lumen central venous cathete …
  • Hagoromo Foods Corp:企業の戦略・SWOT・財務分析
    Hagoromo Foods Corp - Strategy, SWOT and Corporate Finance Report Summary Hagoromo Foods Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Immunogen, Inc.:企業の戦略・SWOT・財務分析
    Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report Summary Immunogen, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Etiqa Insurance Berhad:企業の戦略的SWOT分析
    Etiqa Insurance Berhad - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • InvitroCue Ltd (IVQ)-製薬・医療分野:企業M&A・提携分析
    Summary InvitroCue Ltd (InvitroCue), formerly Bunuru Corporation Ltd is a provider of bio-analytic solutions. The company offers digital pathology services such as digitization, sample preparation, staining, computer aided diagnosis and consultation, telepathology, automated reporting and image arch …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆